NCT02714114View on ClinicalTrials.gov

Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine (AB-SOP Study)

CompletedOBSERVATIONAL
Enrollment

57

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Human Papilloma Virus Infection
Interventions
OTHER

First-void urine collection

One time collection of ca. 20ml of first-void urine (i.e. the initial stream of the urine void) with the Colli-PeeTM device (Novosanis).

OTHER

Blood draw

One time blood sample collection (5-10 cc) by a study nurse of Centre for the Evaluation of Vaccinations (CEV).

Trial Locations (1)

2610

Pierre Van Damme, Wilrijk

All Listed Sponsors
collaborator

Research Foundation Flanders

OTHER

lead

Universiteit Antwerpen

OTHER

NCT02714114 - Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine (AB-SOP Study) | Biotech Hunter | Biotech Hunter